BenjaminM.GastonMD

Professor, Pediatrics, Indiana University

Dr. Gaston is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Wells Center for Pediatric Research, Riley Hospital
1044 W. Walnut St., R4-476
Indianapolis, IN 46202
Phone+1 317-278-2705

Fax+1 434-982-3816

I am a board certified Pulmonologist. I manage severe asthma, Primary Ciliary Dyskinesia and Aerodigestive Disorders

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Pulmonology, 1990 - 1993
National Capital ConsortiumInternship, Transitional Year, 1983 - 1984
University of Virginia School of MedicineClass of 1983

Severe Asthma Research Program Start of enrollment: 2012 Oct 01
Active, not recruiting
Airway Redox and Gender Determinants in Severe Asthma Start of enrollment: 2012 Dec 01
Active, not recruiting
Project 2 Airway Potential Hydrogen (pH) in Asthma Start of enrollment: 2018 Nov 01
Recruiting
Phase 1, Phase 2
GSNOR Phenotyping/GSNO Challenge in Severe Asthma Start of enrollment: 2019 Apr 30
Completed
Early Phase 1
Join now to see all

PubMed

230 citations
Endothelial cell expression of haemoglobin α regulates nitric oxide signalling
Adam C. Straub, Alexander W. Lohman, Marie Billaud, Scott R. Johnstone, Scott Dwyer
Nature. 2012-11-15
291 citations
Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations
Loren C. Denlinger, Brenda R. Phillips, Sima K. Ramratnam, Kristie R. Ross, Nirav R. Bhakta
American Journal of Respiratory and Critical Care Medicine. 2016-08-24
75 citations
Natural killer cell-mediated inflammation resolution is disabled in severe asthma.
Melody G. Duvall, Cindy Barnig, Manuela Cernadas, Isabell Ricklefs, Nandini Krishnamoorthy
Science Immunology. 2017-03-10

Analysis Reveals Rare Disease Is More Common Than Previously ThoughtJanuary 24th, 2022
Atelerix Life Sciences Appoints James Bates, MD, as Chief Medical OfficerSeptember 14th, 2021
Case Western Reserve and Atelerix Life Sciences Inc. Sign Option License to Develop New Therapeutic Approach to Opioid CrisisApril 20th, 2021
Join now to see all

Clinical Centers for the NHLBI's Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE) Network (UG1).NIH2017–2023
Personalized small molecule therapy for severe asthma and cystic fibrosisNIH2016–2021
Airway redox biochemistry as a determinant of asthma phenotypeNIH2011–2020
S-Nitrosothiol Localization And Signaling In Airway Epithelial CellsNational Heart, Lung, And Blood Institute2011–2012
Administrative CoreNational Heart, Lung, And Blood Institute2011–2012
"Cellular S-Nitrosothiol Signaling In Respiratory Biology"National Heart, Lung, And Blood Institute2011–2012
Airway Redox Biochemistry As A Deteriminant Of Asthma Phenotype During Adolescen*National Heart, Lung, And Blood Institute2011
S-Nitrosothiol Breakdown By Airway Epithelial CellsNational Heart, Lung, And Blood Institute1999–2011
Severe Asthma Research ProgramNational Center For Research Resources2008–2010
S-Nitrosotiol Breakdown By Airway Epithelial CellsNational Heart, Lung, And Blood Institute2007
Redox Determinants Of Severe Asthma.National Heart, Lung, And Blood Institute2001–2005
Role Of Airway Epithelial Glutaminase In AsthmaNational Institute Of Allergy And Infectious Diseases2001–2002
Airway Nitrogen Oxide Balance And Cystic Fibrosis: Pilot StudyNational Center For Research Resources1999–2000